ReachRxResearch
Home
Research
Sign Up
The risk of mpox false positive results in high transmission settings: evidence from a multi-site observational study in DR Congo
Back to Research Hub
  1. Home
  2. Research Hub
  3. The risk of mpox false positive results…

The risk of mpox false positive results in high transmission settings: evidence from a multi-site observational study in DR Congo

The Lancet Infectious Diseases·September 15Open Access
Infectious DiseasesPractice changingMpoxMulti-Site Observational StudyQuantitative PCR DiagnosticsMixedMonkeypox Virus QPCR

Summary

View source

What was studied

This multi-site observational study in DR Congo (May 2024–April 2026) quantified the proportion of qPCR-positive mpox diagnoses in outbreak settings that are likely false positives due to environmental MPXV DNA contamination, using a Bayesian latent class model validated against longitudinal serological data in 2,724 suspected cases across four sites.

Key findings

An estimated 35% (95% CrI 31–39%) of qPCR-positive results (Ct <40) were likely false positives from environmental MPXV DNA; lowering the Ct cutoff to <37 reduced the false positive rate to 18%, and to <34 reduced it to 5%, with only marginal sensitivity loss. Serological validation supported this: 88.6% (31/35) of model-inferred false positives had no orthopoxvirus serological evidence, versus 66.7% (20/30) of true infections showing serological evidence.

Study limitations

Serological validation was only available for a subset of participants and orthopoxvirus serology is cross-reactive, limiting specificity of the seroconfirmation. The model relies on assumptions about biological features influencing Ct values, and findings may not generalise beyond high-transmission outbreak settings with heavy environmental contamination.

Clinical implications

In high-transmission mpox settings, consider lowering the qPCR Ct cutoff to <34–37 to substantially reduce false positives while preserving sensitivity, and pair this with enhanced clinic decontamination and clinical/epidemiological follow-up for high-Ct specimens.

Caveats

  • Findings are based on four urban/peri-urban sites in DR Congo and may not generalise to other outbreak geographies or different MPXV clades
  • Over one-third of mpox qPCR positives in these DR Congo outbreak sites may be false positives — this rate is likely specific to high-transmission, resource-limited settings with significant environmental contamination and may not apply to low-transmission or well-resourced settings
  • Serological validation used orthopoxvirus cross-reactive antibodies, which may misclassify results in populations with prior smallpox vaccination or other orthopoxvirus exposure

Related Questions

Explore related topics

What Ct value cutoffs are recommended for mpox qPCR diagnosis to balance sensitivity and specificity?How does environmental DNA contamination affect PCR-based infectious disease surveillance in outbreak settings?What decontamination protocols are effective in reducing MPXV environmental burden in clinical and laboratory settings?

Publication Details

Year
2026
Journal
The Lancet Infectious Diseases
Sample Size
n=2,724
Source
View article
Keep scrolling
More content below.
Up Next